INGELHEIM, Germany - Thursday, August 15th 2013 [ME NewsWire]

    Over 950 patients have now been successfully enrolled in the pivotal Phase III HCVerso™ 1 and 2 trials
    The Phase III study programme includes treatment naïve patients, including those ineligible for interferon and patients with liver cirrhosis
    The milestone coincides with the New England Journal of Medicine publication of SOUND-C2: one of the largest interferon-free studies in genoytpe-1 HCV published to date, forming the basis of the HCVerso™ trials

(BUSINESS WIRE)

For media outside USA, UK and Canada only

Boehringer Ingelheim today announced that enrolment of over 950 treatment naïve genotype-1b patients in the pivotal Phase III interferon-free HCVerso™ 1 and 2 trials is complete.1,2 The trials are investigating the efficacy and safety of Boehringer Ingelheim’s second generation protease inhibitor faldaprevir* and NS5B polymerase inh ... Read more »

ME NewsWire / BusinessWire

RALEIGH, N.C. & LONDON - Thursday, August 15th 2013

Sensus, a leading utility infrastructure company, has been selected to provide the core communications technology to support one of the world’s largest smart metering projects — the UK government’s plan to put smart meters in millions of homes and small businesses by 2020. Sensus technology will support the rollout of electric and gas smart meters to ten million locations in the Northern region of Great Britain, subject to contract.

"The selection validates that our technology has no borders,” said Sensus CEO and President Peter Mainz. "Further, it provides financial and energy savings for utilities and consumers by improving operational efficiency and enabling the public to make informed choices on their energy use.”

The UK Department of Energy and Climate Change (DECC) announced today that communications company Arqiva has been selected as preferred bidder to provide the sma ... Read more »